SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-082618
Filing Date
2022-12-23
Accepted
2022-12-23 16:30:13
Documents
14
Period of Report
2022-12-20
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea170702-8k_aditxt.htm   iXBRL 8-K 28530
2 AMENDMENT NO. 2 TO SERIES C WARRANT AGENT AGREEMENT ea170702ex10-1_aditxt.htm EX-10.1 14035
3 FORM OF AMENDED AND RESTATED UNIT PURCHASE OPTION ea170702ex10-2_aditxt.htm EX-10.2 58952
  Complete submission text file 0001213900-22-082618.txt   298452

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE adtx-20221220.xsd EX-101.SCH 3221
5 XBRL LABEL FILE adtx-20221220_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE adtx-20221220_pre.xml EX-101.PRE 22355
8 EXTRACTED XBRL INSTANCE DOCUMENT ea170702-8k_aditxt_htm.xml XML 3693
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 221485680
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences